TREATMENT OF CARDIAC ARRHYTHMIAS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140200183A1
SERIAL NO

14221634

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compositions of the invention, including compounds that bind to a receptor for a glucagon-like peptide-1, an incretin, a glucagon-like peptide-1 (GLP-1), an exendin, or an agonist, an analog (preferably an agonist analog), a derivative, or a variant of any of aforementioned compounds, are used in the prevention and treatment of arrhythmias associated with cardiac ischemia, cardiac ischemia-perfusion and/or congestive heart failure. The invention relates to both the method and compositions for such treatment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASTRAZENECA PHARMACEUTICALS LPWILMINGTON DE 19850

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BARON, Alain D San Diego, US 44 1018
HATHAWAY, David R Lincoln, US 14 1316

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation